Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

2Q16 Public-Private Partnership Roundup

Highlights of public-private partnerships from 2Q16

August 4, 2016 7:00 AM UTC

A new consortia revival helped boost public-private partnerships (PPPs) in 2Q16 to the highest total in two years. Newly announced preclinically focused deals jumped 30% over the relatively sluggish first quarter, from 56 PPPs to 71.

In previous analyses, stakeholders told BioCentury the field was starting to show "consortia fatigue." In 2015, BioCentury Innovations tracked 20 PPP consortia - defined as new partnerships involving four or more academic or industry partners. That trend spilled into this year, with only three new consortia announced in 1Q16. However, in 2Q16, nine new consortia were announced, including seven composed mostly of U.S.-based academic or industry partners (see Figure: PPP Consortia). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article